Physician profile
Katherine Orehek
NPI 1669148771
$394.96
in general payments reported to CMS, 2019-2025
12 companies · $95.06 in 2025
The $95.06 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.59 · 2023: $180 · 2024: $53.67 · 2025: $95.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302 · Education: $26.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.64 |
| Education | $26.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $83.89 | 2021-2023 | |
| Exact Sciences Corporation | $65.24 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $56.74 | 2023-2024 | |
| Biocryst US Sales Co., LLC | $36.28 | 2025 | Orladeyo |
| Biogen, INC. | $30.24 | 2021 | |
| Novartis Pharmaceuticals Corporation | $29.12 | 2023 | |
| Depuy Synthes Sales INC. | $24.80 | 2024 | Monovisc, Orthovisc |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.44 | 2025 | Caplyta |
| Lilly USA, LLC | $16.14 | 2023 | Mounjaro |
| Lundbeck LLC | $14.64 | 2023 | Rexulti |
| Boston Scientific Corporation | $12.38 | 2025 | Axonics |
| Life Molecular Imaging LTD | $9.05 | 2023 | Neuraceq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Orehek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.